Insulin Pump Therapy

An insulin pump is a small battery-powered device that delivers rapid-acting insulin under the skin through a cannula, a soft plastic tube or steel needle that you change every two to three days. Tubed pumps are worn on a belt or in a pocket and connected to the cannula by thin tubing. Patch pumps, also called tubeless pumps, hold the insulin in a small pod stuck directly to the skin and are controlled by a handheld device or phone. The pump gives basal insulin, a programmed background flow that can vary through the day, and bolus doses for meals and corrections, calculated by a built-in adviser from your carbohydrate intake and glucose level. A continuous glucose monitor uses a small sensor under the skin to measure glucose every few minutes. In automated insulin delivery, an algorithm uses these readings to adjust insulin automatically, stopping it when glucose falls and increasing it when glucose rises, while you still give meal doses in most current systems.

Pump therapy is most often recommended for people with type 1 diabetes whose glucose control is not on target despite careful use of multiple daily injections, or who have frequent or severe low blood sugars, reduced awareness of lows, or a marked rise in glucose in the early morning. It is widely used in children, including young children, whose insulin needs are small and vary greatly, and in women planning pregnancy or who are pregnant, when tight control matters. Automated insulin delivery is now recommended for many people with type 1 diabetes as a way to improve time in range and reduce the burden of daily management. People with irregular work patterns, shift work or high levels of sport may find a pump easier to adapt. Some people with type 2 diabetes who need several insulin injections a day also benefit. A pump is not a cure and still needs daily attention, so motivation and willingness to learn matter as much as medical reasons.

A pump start usually takes place over a few days in an outpatient diabetes centre. Before the start, you may attend a structured education course on carbohydrate counting and insulin adjustment if you have not done one. You choose a pump and, where relevant, a compatible sensor with the team. On the first day a diabetes nurse or educator explains the device, sets the initial basal rates, carbohydrate ratios, correction factor and glucose targets calculated from your current insulin doses, and teaches you to fill the reservoir or pod, insert the cannula and sensor, and give meal doses. Some centres first run the pump with saline for a day so you can practise. Over the following days you check glucose patterns with the team, adjust settings, and learn how to handle exercise, illness, alcohol and lows. Automated mode is usually switched on once the system has learned your needs. You also practise what to do if the pump fails.

Good candidates are people with diabetes treated with insulin who are willing to check glucose levels, count carbohydrates, change sites regularly and respond to alarms, or who have a parent or carer to do this for them. Before the start, the team reviews your diabetes history, insulin doses, glucose records, HbA1c, low blood sugars and any complications, and checks kidney and thyroid function. A recent download from your glucose meter or sensor helps set the first pump settings. Confirm in advance that the chosen pump, sensors and consumables can be obtained and supported near home, and that your home diabetes team can view the pump data, because a device without local supplies and support is not workable. Bring all your current insulin, pens and testing supplies. International patients should allow about a week, including a few days of supervised use, and should arrange data sharing so the team can review glucose patterns remotely after you return home.

There is no physical recovery after starting a pump; you continue normal life from the first day, although learning the device takes concentration and the first weeks involve frequent adjustments. Low blood sugars can occur while settings are refined, so check glucose often and carry fast-acting sugar. When planning travel, ask the team for a written summary of your pump settings, and keep insulin pens with long-acting and rapid-acting insulin as a backup in case of pump failure. Many manufacturers advise not putting pumps and sensors through airport body scanners or X-ray machines; carry a letter explaining your device and ask for a hand search. Change the pump clock gradually or at arrival when crossing time zones, as your team advises. Keep insulin cool and carry spare cannulas, reservoirs, sensors and batteries in your hand luggage. Agree a follow-up schedule, usually remote checks in the first weeks, then reviews about every three months with your home team.

Insulin pumps are widely used and safe when people are well trained. The most serious risk is diabetic ketoacidosis: because the pump uses only rapid-acting insulin, a blocked or dislodged cannula, a kink in the tubing or a device fault can stop insulin delivery, and ketones can rise within a few hours. Checking ketones when glucose is unexpectedly high and changing the cannula or switching to pens if it does not respond is the key safety rule. Low blood sugars can occur while settings are adjusted, although automated systems generally reduce them. Skin problems at infusion sites include irritation, allergy to adhesives, infection and lumpy areas from repeated use of the same spot, so sites should be rotated. Sensor readings occasionally differ from finger-prick tests. Many people see improved HbA1c, more time in range and fewer severe lows within a few months, along with greater flexibility around meals, exercise and sleep.